PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Medical Virology, University of Zurich, Zurich, Switzerland.\', \'Life Science Zurich Graduate School, ETH and University of Zurich, Zurich, Switzerland.\', \'Institute of Medical Virology, University of Zurich, Zurich, Switzerland stertz.silke@virology.uzh.ch hale.ben@virology.uzh.ch.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e01928-2010.1128/mBio.01928-20
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 32913009
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32913009>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32913009>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all